Respiratory System — MCQs

Respiratory System Indian Medical PG Practice Questions and MCQs

Question 401: The vasodilatation produced by carbon dioxide is maximum in which of the following organs?

A. Kidney
B. Brain (Correct Answer)
C. Liver
D. Heart

Explanation: **Explanation:** The correct answer is **Brain (Option B)**. **1. Why Brain is Correct:** The cerebral circulation is uniquely sensitive to arterial carbon dioxide tension ($PaCO_2$). Carbon dioxide is the most potent physiological regulator of cerebral blood flow. When $PaCO_2$ levels rise (hypercapnia), $CO_2$ diffuses across the blood-brain barrier into the perivascular fluid, where it reacts with water to form carbonic acid, releasing hydrogen ions ($H^+$). This local drop in pH causes profound relaxation of the vascular smooth muscle in cerebral arterioles, leading to significant vasodilatation. This mechanism ensures that metabolic waste is cleared and adequate oxygenation is maintained during periods of high metabolic activity. **2. Why Other Options are Incorrect:** * **Kidney (Option A):** Renal blood flow is primarily regulated by autoregulation (myogenic and tubuloglomerular feedback) and the sympathetic nervous system. While $CO_2$ can have minor effects, it is not the primary vasodilator. * **Liver (Option B):** Hepatic blood flow is largely determined by portal venous return and the "Hepatic Artery Buffer Response" (adenosine-mediated), rather than $CO_2$ sensitivity. * **Heart (Option D):** While $CO_2$ and $H^+$ do cause coronary vasodilatation, the most potent metabolic regulator of coronary blood flow is **Adenosine**, followed by hypoxia. **3. NEET-PG High-Yield Pearls:** * **Linear Relationship:** Within the range of 20–80 mmHg, cerebral blood flow (CBF) changes linearly with $PaCO_2$. For every 1 mmHg rise in $PaCO_2$, CBF increases by approximately 2-3%. * **Hypoxic Vasoconstriction:** Note the contrast—in the **Lungs**, high $CO_2$ and low $O_2$ cause *vasoconstriction* (to shunt blood to better-ventilated alveoli), whereas in the **Brain**, they cause *vasodilation*. * **Clinical Application:** Therapeutic hyperventilation is used in neurosurgery to lower $PaCO_2$, causing cerebral vasoconstriction to reduce intracranial pressure (ICP).

Question 402: If at the beginning of inspiration, pulmonary compliance is 0.2 L/cm H2O and the initial trans-pulmonary pressure is 5 cm H2O, what will be the transpulmonary pressure after inhaling 600 mL of air?

A. 4 cm H2O
B. 7 cm H2O
C. 8 cm H2O (Correct Answer)
D. 9 cm H2O

Explanation: ### Explanation **1. Understanding the Correct Answer (C: 8 cm H2O)** The core concept here is the relationship between **Pulmonary Compliance ($C$)**, **Volume change ($\Delta V$)**, and **Pressure change ($\Delta P$)**. Compliance is defined as the change in lung volume per unit change in transpulmonary pressure: $$C = \frac{\Delta V}{\Delta P}$$ To find the new transpulmonary pressure, we first calculate the change in pressure ($\Delta P$) required to inhale 600 mL (0.6 L) of air: * **Given:** $C = 0.2 \text{ L/cm H}_2\text{O}$; $\Delta V = 0.6 \text{ L}$ * **Formula:** $\Delta P = \frac{\Delta V}{C}$ * **Calculation:** $\Delta P = \frac{0.6}{0.2} = 3 \text{ cm H}_2\text{O}$ The transpulmonary pressure ($P_{tp}$) must **increase** to expand the lungs. * **Final $P_{tp}$** = Initial $P_{tp}$ + $\Delta P$ * **Final $P_{tp}$** = $5 \text{ cm H}_2\text{O} + 3 \text{ cm H}_2\text{O} = \mathbf{8 \text{ cm H}_2\text{O}}$. **2. Why Other Options are Incorrect** * **Option A (4 cm H2O):** This suggests a decrease in pressure, which occurs during expiration, not inspiration. * **Option B (7 cm H2O):** This would be the result if the tidal volume was only 400 mL ($0.2 \times 2 = 0.4$). * **Option D (9 cm H2O):** This would imply a lower compliance (0.15 L/cm H2O) or a higher inhaled volume (800 mL). **3. Clinical Pearls & High-Yield Facts** * **Transpulmonary Pressure ($P_{tp}$):** It is the difference between Alveolar pressure ($P_{alv}$) and Intrapleural pressure ($P_{ip}$). It is always positive under normal physiological conditions to keep the lungs inflated. * **Compliance Trends:** * **Decreased Compliance:** Seen in Pulmonary Fibrosis, ARDS, and Pulmonary Edema (lungs are "stiff"). * **Increased Compliance:** Seen in Emphysema (loss of elastic recoil) and with aging. * **Specific Compliance:** Compliance divided by Functional Residual Capacity (FRC); used to compare lungs of different sizes.

Question 403: Diffusion capacity for carbon monoxide is decreased in all of the following conditions EXCEPT:

A. Chronic Bronchitis (Correct Answer)
B. Emphysema
C. Interstitial lung disease
D. Pulmonary embolism

Explanation: **Explanation:** The **Diffusion Capacity of the Lung for Carbon Monoxide (DLCO)** measures the ability of the lungs to transfer gas from inhaled air to the red blood cells in pulmonary capillaries. It depends on three main factors: the surface area of the blood-gas barrier, the thickness of the alveolar-capillary membrane, and the pulmonary capillary blood volume. **Why Chronic Bronchitis is the Correct Answer:** In **Chronic Bronchitis**, the primary pathology involves inflammation of the airways and mucus hypersecretion. Crucially, the **alveolar-capillary unit remains intact**, and there is no significant destruction of the alveolar walls. Therefore, the DLCO remains **normal** (or occasionally slightly increased). This is a key physiological differentiator between Chronic Bronchitis ("Blue Bloaters") and Emphysema. **Why the other options are incorrect:** * **Emphysema:** Characterized by the destruction of alveolar walls, leading to a permanent increase in air space size. This significantly **reduces the surface area** available for gas exchange, thus decreasing DLCO. * **Interstitial Lung Disease (ILD):** Conditions like pulmonary fibrosis increase the **thickness** of the alveolar-capillary membrane, creating a barrier to diffusion and decreasing DLCO. * **Pulmonary Embolism:** This obstructs blood flow to the alveoli. Even if the alveoli are ventilated, the lack of perfusion (decreased **pulmonary capillary blood volume**) results in a drop in DLCO. **High-Yield Clinical Pearls for NEET-PG:** * **DLCO is Increased in:** Polycythemia, Alveolar hemorrhage (e.g., Goodpasture syndrome), Left-to-right shunts, and Exercise. * **DLCO is Decreased in:** Anemia, Emphysema, ILD, Pulmonary Hypertension, and Sarcoidosis. * **The "Gold Standard" Rule:** If a patient has obstructive lung disease (low FEV1/FVC), a **low DLCO points to Emphysema**, while a **normal DLCO points to Asthma or Chronic Bronchitis.**

Question 404: In a transection at the pontomedullary junction, respiration is maintained with slight irregularity. This is due to which structure?

A. Pre-Botzinger complex (Correct Answer)
B. Pneumotaxic centre
C. Apneustic Centre
D. Dorsal respiratory group

Explanation: ### Explanation **1. Why the Correct Answer is Right:** The **Pre-Bötzinger complex (pre-BötC)** is the primary pacemaker of respiration, located in the ventrolateral medulla. It contains specialized neurons that exhibit spontaneous rhythmic activity, similar to the SA node in the heart. * **The Mechanism:** When a transection occurs at the **pontomedullary junction**, the medulla is separated from the pons. Since the pre-BötC is located within the medulla, it continues to generate the basic respiratory rhythm independently. However, because it is no longer receiving fine-tuning signals from the pontine centers (Pneumotaxic and Apneustic), the resulting breathing pattern is rhythmic but slightly irregular or gasping in nature. **2. Why the Incorrect Options are Wrong:** * **B. Pneumotaxic Centre:** Located in the upper pons (nucleus parabrachialis). It functions as an "off-switch" for inspiration. If the cut is at the pontomedullary junction, this center is removed from the circuit and cannot maintain respiration. * **C. Apneustic Centre:** Located in the lower pons. It promotes inspiration. Like the pneumotaxic center, it is located above the medulla and is excluded by a pontomedullary transection. * **D. Dorsal Respiratory Group (DRG):** Located in the medulla, the DRG is primarily responsible for the *integration* of sensory input (via the Vagus and Glossopharyngeal nerves) and driving inspiration. While it is in the medulla, it is not the primary rhythm generator; it relies on the pre-BötC for the underlying pace. **3. High-Yield Facts for NEET-PG:** * **Location Summary:** * Pons: Pneumotaxic (Upper) & Apneustic (Lower) centers. * Medulla: DRG (Inspiration), VRG (Expiration), and Pre-Bötzinger (Pacemaker). * **Sectioning Effects:** * **Vagus nerve cut + Pneumotaxic center removed:** Results in **Apneusis** (prolonged inspiratory gasps). * **Below Medulla (C3-C5):** Total cessation of breathing (death) as the connection to the phrenic nerve is lost. * **Pre-Bötzinger Complex** is considered the "Respiratory Rhythm Generator."

Question 405: An increase in which of the following increases the O2 affinity of hemoglobin?

A. Temperature
B. PCO2
C. H+ concentration
D. Carbon monoxide added to the blood (Correct Answer)

Explanation: This question tests your understanding of the **Oxygen-Hemoglobin Dissociation Curve**. A shift to the **left** indicates increased O2 affinity (hemoglobin holds onto O2), while a shift to the **right** indicates decreased affinity (hemoglobin releases O2). ### **Why Option D is Correct** **Carbon Monoxide (CO)** has a dual effect on hemoglobin: 1. **Competitive Binding:** CO binds to heme with an affinity ~240 times greater than O2, forming carboxyhemoglobin. 2. **Allosteric Modification:** When CO binds to one of the four heme sites, it causes a conformational change in the remaining heme groups, increasing their affinity for the already bound oxygen. This shifts the curve to the **left**, preventing the unloading of oxygen to tissues. ### **Why Other Options are Incorrect** Options A, B, and C are factors that cause a **Right Shift** (Decreased affinity). This is often remembered by the mnemonic **"CADET, face Right!"** (CO2, Acid/H+, DPG, Exercise, Temperature). * **A. Temperature:** Increased temperature (e.g., during fever or exercise) decreases affinity to help unload O2 to active tissues. * **B. PCO2:** Increased CO2 leads to the **Bohr Effect**, decreasing affinity. * **C. H+ Concentration:** A decrease in pH (acidosis) stabilizes the T-state (tense) of hemoglobin, reducing its affinity for O2. ### **High-Yield Clinical Pearls for NEET-PG** * **Left Shift Factors:** ↓ Temp, ↓ H+ (Alkalosis), ↓ 2,3-DPG, ↓ PCO2, HbF (Fetal Hb), and CO poisoning. * **The Bohr Effect:** Describes how CO2 and H+ affect O2 affinity (Right shift). * **The Haldane Effect:** Describes how O2 concentration affects Hb's affinity for CO2 (Oxyhemoglobin makes Hb a weaker acid, promoting CO2 release in lungs). * **CO Poisoning Paradox:** Even though the O2 content of blood is reduced, the PaO2 (partial pressure of dissolved O2) remains normal, which is why the carotid bodies are not stimulated and there is no initial respiratory distress.

Question 406: A person unacclimatized develops pulmonary edema in approximately how many days?

A. 2-3 days (Correct Answer)
B. 6-7 days
C. 19-21 days
D. 2nd-3rd month

Explanation: **Explanation:** The question refers to **High-Altitude Pulmonary Edema (HAPE)**, a life-threatening form of non-cardiogenic pulmonary edema that occurs in unacclimatized individuals who ascend rapidly to altitudes typically above 2,500 meters (8,000 feet). **1. Why 2-3 days is correct:** HAPE typically manifests **2 to 4 days** after arrival at high altitude. The underlying mechanism is **Hypoxic Pulmonary Vasoconstriction (HPV)**. In response to low alveolar oxygen, pulmonary arterioles constrict to divert blood to better-ventilated areas. However, at high altitudes, this constriction is global and uneven, leading to increased pulmonary capillary pressure, "stress failure" of the alveolar-capillary membrane, and subsequent leakage of fluid into the lungs. **2. Analysis of Incorrect Options:** * **6-7 days:** By this time, the initial acute phase of mountain sickness has usually either resolved through early acclimatization or progressed to severe illness. HAPE is an acute-onset condition. * **19-21 days:** This timeframe is associated with more advanced hematological adaptations, such as increased erythropoiesis (polycythemia), rather than acute edema. * **2nd-3rd month:** This duration is characteristic of **Chronic Mountain Sickness (Monge’s Disease)**, which involves pulmonary hypertension and right heart failure due to long-term exposure, not acute pulmonary edema. **Clinical Pearls for NEET-PG:** * **Early Sign:** The earliest sign of HAPE is often a **reduction in exercise tolerance** and prolonged recovery time. * **Treatment of Choice:** Immediate **descent** is the most definitive treatment. * **Pharmacotherapy:** **Nifedipine** (a calcium channel blocker) is used for prevention and treatment as it reduces pulmonary artery pressure. **Acetazolamide** helps in prevention by stimulating ventilation. * **Key Feature:** Unlike cardiogenic edema, the pulmonary capillary wedge pressure (PCWP) in HAPE remains **normal**.

Question 407: Which hormone stimulates respiration?

A. Estrogen
B. Progesterone (Correct Answer)
C. Corticosteroids
D. Prolactin

Explanation: **Explanation:** **Progesterone** is a potent respiratory stimulant. It acts through two primary mechanisms: 1. **Central Stimulation:** It increases the sensitivity of the respiratory center in the medulla to Carbon Dioxide ($CO_2$). 2. **Direct Action:** It acts as a direct stimulant to the respiratory drive, increasing tidal volume and minute ventilation. This physiological effect is most evident during the **luteal phase** of the menstrual cycle and during **pregnancy**, where elevated progesterone levels lead to chronic hyperventilation. This results in a physiological decrease in arterial $PCO_2$ (hypocapnia), creating a favorable $CO_2$ gradient for the fetus to excrete waste. **Analysis of Incorrect Options:** * **A. Estrogen:** While estrogen can enhance the effect of progesterone by increasing progesterone receptor expression, it does not independently stimulate respiration to a significant degree. * **C. Corticosteroids:** These primarily influence metabolic and anti-inflammatory pathways. While they are used to treat respiratory distress (e.g., asthma or fetal lung maturity), they do not act as physiological stimulants of the respiratory center. * **D. Prolactin:** This hormone is primarily involved in lactation and reproductive suppression; it has no documented role in stimulating the respiratory drive. **High-Yield Clinical Pearls for NEET-PG:** * **Pregnancy Physiology:** Pregnant women often experience "physiological dyspnea" due to progesterone-induced hyperventilation, leading to a state of **compensated respiratory alkalosis**. * **Therapeutic Use:** Medroxyprogesterone (a synthetic progestin) has been used clinically to treat **Obstructive Sleep Apnea (OSA)** and **Pickwickian Syndrome** (Obesity Hypoventilation Syndrome) due to its ventilatory stimulatory effects. * **Acid-Base Balance:** In pregnancy, the normal $PaCO_2$ drops to approximately **30–32 mmHg** (Normal: 40 mmHg).

Question 408: Which of the following factors is responsible for the pulmonary alveoli to be kept dry under normal circumstances?

A. Macrophages
B. Tight junction between endothelium and alveolar surface
C. Pulmonary surfactant
D. Negative interstitial pressure (Correct Answer)

Explanation: **Explanation:** The prevention of pulmonary edema and the maintenance of "dry" alveoli are governed by **Starling’s forces**. Under normal physiological conditions, the net movement of fluid is out of the pulmonary capillaries and into the interstitial space. **Why Negative Interstitial Pressure is Correct:** The pulmonary interstitial pressure is approximately **-5 to -8 mmHg**. This negative pressure acts as a "vacuum," drawing any excess fluid that filters out of the capillaries into the interstitium. From there, the fluid is efficiently removed by the extensive **pulmonary lymphatic system**. This constant drainage ensures that fluid does not accumulate or cross the alveolar-capillary membrane into the air spaces, keeping the alveoli dry for optimal gas exchange. **Analysis of Incorrect Options:** * **Macrophages (A):** These are immune cells responsible for phagocytosing debris and pathogens; they do not regulate fluid dynamics. * **Tight Junctions (B):** While the alveolar epithelium has "tight" junctions that limit permeability, they are a structural barrier rather than the active physiological mechanism responsible for dryness. * **Pulmonary Surfactant (C):** Surfactant reduces surface tension to prevent alveolar collapse (atelectasis). While it indirectly helps by reducing the inward "suction" force on capillaries, its primary role is lung compliance, not fluid drainage. **High-Yield Clinical Pearls for NEET-PG:** * **Safety Factor:** The pulmonary capillary hydrostatic pressure must rise from its normal (~7 mmHg) to above the plasma colloid osmotic pressure (~28 mmHg) before significant alveolar edema occurs. This is known as the "Safety Factor" against pulmonary edema. * **Zone of West:** Blood flow is highest at the base of the lung (Zone 3) because the capillary pressure is highest there, making it the most common site for early edema. * **J-Receptors:** Located in the alveolar walls, these are stimulated by interstitial fluid accumulation, leading to rapid, shallow breathing (tachypnea).

Question 409: What is the most potent vasoconstrictor of the pulmonary artery?

A. Endothelin
B. Hypoxia (Correct Answer)
C. Angiotensin
D. TXA2

Explanation: **Explanation:** The correct answer is **Hypoxia**. In the pulmonary circulation, hypoxia triggers a unique physiological response known as **Hypoxic Pulmonary Vasoconstriction (HPV)**. Unlike systemic blood vessels, which dilate in response to low oxygen to increase blood flow, pulmonary arterioles constrict. This mechanism shunts blood away from poorly ventilated alveoli toward well-ventilated areas of the lung, optimizing ventilation-perfusion (V/Q) matching and preventing shunting. **Analysis of Options:** * **Hypoxia (Correct):** It is the most potent and physiologically significant stimulus for pulmonary vasoconstriction. It acts directly on pulmonary vascular smooth muscle cells by inhibiting voltage-gated potassium channels, leading to depolarization and calcium influx. * **Endothelin:** While Endothelin-1 is a powerful endogenous vasoconstrictor, it is not the primary physiological regulator of pulmonary vascular resistance compared to the immediate and potent effect of hypoxia. * **Angiotensin:** Angiotensin II is a potent systemic vasoconstrictor. While it can constrict pulmonary vessels, its effect is secondary and less potent than the localized response to hypoxia. * **TXA2 (Thromboxane A2):** This is a potent vasoconstrictor and platelet aggregator released during injury or inflammation, but it is not the "most potent" or primary regulator of pulmonary tone. **Clinical Pearls for NEET-PG:** * **V/Q Matching:** HPV is the lung's primary defense against hypoxemia. * **High Altitude:** Global hypoxia at high altitudes causes generalized pulmonary vasoconstriction, leading to **High-Altitude Pulmonary Edema (HAPE)**. * **Opposite Effects:** Remember: Hypoxia causes **vasodilation** in systemic circulation but **vasoconstriction** in pulmonary circulation. * **Nitric Oxide (NO):** The most potent pulmonary **vasodilator**.

Question 410: Which muscle is responsible for the change in pitch of sound?

A. Posterior cricoarytenoids
B. Lateral cricoarytenoids
C. Cricothyroid (Correct Answer)
D. Vocalis

Explanation: **Explanation:** The pitch of the human voice is primarily determined by the **tension and length** of the vocal folds. **Why Cricothyroid is correct:** The **Cricothyroid muscle** is known as the "tensing muscle" of the larynx. When it contracts, it tilts the thyroid cartilage forward or pulls the cricoid cartilage upward. This action increases the distance between the thyroid and arytenoid cartilages, thereby **stretching and tensing** the vocal folds. Increased tension leads to a higher frequency of vibration, which results in a **higher pitch**. **Analysis of Incorrect Options:** * **Posterior cricoarytenoids:** These are the only **abductors** of the vocal folds (opening the glottis). Their primary role is respiratory, not pitch modulation. * **Lateral cricoarytenoids:** These are the primary **adductors** of the vocal folds, closing the glottis for phonation. * **Vocalis:** This muscle (the medial part of the thyroarytenoid) adjusts the local tension of the vocal folds. While it helps in fine-tuning the voice and "thickening" the folds to lower pitch, the primary muscle responsible for the gross change in pitch (especially high pitch) is the cricothyroid. **High-Yield Clinical Pearls for NEET-PG:** * **Nerve Supply:** All intrinsic muscles of the larynx are supplied by the **Recurrent Laryngeal Nerve (RLN)**, EXCEPT the **Cricothyroid**, which is supplied by the **External Laryngeal Nerve**. * **Safety Muscle:** The **Posterior Cricoarytenoid** is the "safety muscle of the larynx" because it is the only muscle that opens the airway. * **Injury:** Damage to the external laryngeal nerve (often during thyroid surgery) leads to an inability to tense the vocal folds, resulting in a **hoarse voice and loss of high-pitched notes** (important for singers).

Practice by Chapter

Mechanics of Breathing

Practice Questions

Pulmonary Ventilation

Practice Questions

Pulmonary Circulation

Practice Questions

Gas Exchange in the Lungs

Practice Questions

Oxygen and Carbon Dioxide Transport

Practice Questions

Control of Breathing

Practice Questions

Respiratory Adjustments in Health and Disease

Practice Questions

High Altitude Physiology

Practice Questions

Diving Physiology

Practice Questions

Respiratory Function Tests

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free